Clinical TrialsSearch results
Number of results: 395
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Other
- Study of imatinib monotherapy and combination of imatinib with IFN or cytarabine ocfosfate for chronic-phase CML (JALSG CML202 Study)
- Previously untreated chronic-phase chronic myelogenous leukemia
- Japan Adult Leukemia Study Group
- 2005-09-10
Other
- Study of Assessment for Kidney function by Urinary microalbumin in RAndomized Trial
- Hypertension with diabetic nephropathy
- The University of Tokyo Graduate School of Medicine
- 2008-07-14
Other
- Study of Advanced life support for Ventricular fibrillation with Extracorporeal circulation in Japan
- Cardiopulmonary arrest on arrival(CPAOA)
- Teikyo University School of Medicine, Teikyo University Hospital
- 2008-10-01
Other
- Study for the effectiveness of intensive therapy for diabetic nephropathy in unblinded, randomized intergroup comparison study.
- Diabetic Nephropathy
- Okayama University Hospital
- 2005-11-16
Other
- Specimen Aquisition Program and Genetic Analysis for Myelodysplastic Syndromes
- Myelodysplastic Syndromes
- Keio University School of Medicine
- 2007-04-28
Other
- Safety of Biologics in Clinical Use in Japanese Patients with Rheumatoid Arthritis in Long-Term (SECURE)
- Rheumatoid Arthritis
- Japan College of Rheumatology
- 2008-09-01
Other
- Safety and efficacy of preoperative chemotherapy with mFOLFOX6+Bevacizumab in patients with liver-only metastases (H2, H3) from colorectal cancer; histological assessment of liver damage from preoperative chemotherapy.
- Patients with liver-only metastases from colorectal cancer
- Kyushu Study group of Clinical Cancer
- 2008-08-08
Other
- Safety and Efficacy of Bortezomib inaddtion to Adriamycin and Intermediate-Dose Dexamethasone (iPAD) in Subjects with Relapse/Refractory Multiple Myeloma with Primary Therapies ; A PhaseI/II, Multicentre, Open-Label, Single-Arm Study
- Relapse/Refractory Multiple Myeloma
- Division of Medical Oncology, Hematology and Infectious Disease, Department of Medicine, Fukuoka University
- 2008-06-26
Other
- Safety and efficacy of Alternating mFOLFOX6 plus bevacizumab and FOLFIRI plus bevacizumab every 4cycles as First line Therapy in Advanced colorectal Cancer
- Unresectable advanced/recurrent colorectal cancer
- KSCC
- 2008-08-12
Other
- Safety and efficacy of Alternating mFOLFOX6 and FOLFIRI every 4cycles as First line Therapy in Advanced colorectal Cancer
- Unresectable advanced/recurrent colorectal cancer
- KSCC
- 2008-08-29